Browse drugs

…ural complexity. tenecteplase has pharmacologic advantages over alteplase, including greater fibrin specificity and longer half-life, whi…

…unctional outcome, but functional outcomes were similar between Tenecteplase and alteplase overall.Conclusions We observed higher early repe…

…4) subgroups and in patients aged ≥90 years (n=160).Conclusions Tenecteplase and alteplase showed comparable efficacy and safety in patients…

…us thrombolytics are the only accessible reperfusion treatment. Tenecteplase is established as the preferred thrombolytic for selected patie…

…t known well. Patients will be randomised to either intravenous tenecteplase (0.25 mg/kg, maximum 25 mg) or standard care. EVT is allowed in…

…e and renal impairment complications, particularly for the drug tenecteplase. Therefore, we examined the association of impaired renal funct…

…d with greater early thrombus movement before EVT compared with alteplase. In this cohort thrombus movement category did not predict 90-d…

…289 Figure 1Recanalization rate by occlusion location following tenecteplase administration. Spontaneous recanalization occurred more freque…

… thrombolytic administered within 4.5 hours of stroke symptoms. Tenecteplase (TNK) is FDA-approved for STEMI, but its off-label use for AIS …

…3.0%). Tenecteplase recipients (n=252) had higher TM rates than alteplase recipients (19.4% vs 11.5%, adjusted OR (aOR) 1.83, 95% CI 1.10…

…, and functional dependency (28.1% vs 22.8%, p=0.37).Conclusion TNK and tPA demonstrated comparable safety and mortality in BAO tre…

…with an embolic stroke of undetermined source and discharged on aspirin.Conclusions Standard stroke assessments incompletely characteri…